Aprea Therapeutics, Inc. (APRE) Operating income 2021–2025
Aprea Therapeutics, Inc. (APRE) annual operating income history from SEC filings — each fiscal year as reported.
-$13.2MFY2025 · since FY2021: -$37.4M → -$13.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$13.2M | +7.6% |
| FY2024 | -$14.3M | +7.4% |
| FY2023 | -$15.5M | +86.4% |
| FY2022 | -$113.4M | -202.8% |
| FY2021 | -$37.4M | — |
Source: SEC XBRL filings · For reference only · Not investment advice